These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 18796164)
1. Somatic mutation analysis of MYH11 in breast and prostate cancer. Alhopuro P; Karhu A; Winqvist R; Waltering K; Visakorpi T; Aaltonen LA BMC Cancer; 2008 Sep; 8():263. PubMed ID: 18796164 [TBL] [Abstract][Full Text] [Related]
2. Unregulated smooth-muscle myosin in human intestinal neoplasia. Alhopuro P; Phichith D; Tuupanen S; Sammalkorpi H; Nybondas M; Saharinen J; Robinson JP; Yang Z; Chen LQ; Orntoft T; Mecklin JP; Järvinen H; Eng C; Moeslein G; Shibata D; Houlston RS; Lucassen A; Tomlinson IP; Launonen V; Ristimäki A; Arango D; Karhu A; Sweeney HL; Aaltonen LA Proc Natl Acad Sci U S A; 2008 Apr; 105(14):5513-8. PubMed ID: 18391202 [TBL] [Abstract][Full Text] [Related]
3. Somatic Mutations and Intratumoral Heterogeneity of MYH11 Gene in Gastric and Colorectal Cancers. Jo YS; Kim MS; Yoo NJ; Lee SH Appl Immunohistochem Mol Morphol; 2018 Sep; 26(8):562-566. PubMed ID: 29517504 [TBL] [Abstract][Full Text] [Related]
4. Graded effects of unregulated smooth muscle myosin on intestinal architecture, intestinal motility and vascular function in zebrafish. Abrams J; Einhorn Z; Seiler C; Zong AB; Sweeney HL; Pack M Dis Model Mech; 2016 May; 9(5):529-40. PubMed ID: 26893369 [TBL] [Abstract][Full Text] [Related]
5. Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer. Jonsson BA; Bergh A; Stattin P; Emmanuelsson M; Grönberg H Int J Cancer; 2002 Apr; 98(6):838-43. PubMed ID: 11948460 [TBL] [Abstract][Full Text] [Related]
6. 16p13.11 microdeletion uncovers loss-of-function of a MYH11 missense variant in a patient with megacystis-microcolon-intestinal-hypoperistalsis syndrome. Kloth K; Renner S; Burmester G; Steinemann D; Pabst B; Lorenz B; Simon R; Kolbe V; Hempel M; Rosenberger G Clin Genet; 2019 Jul; 96(1):85-90. PubMed ID: 31044419 [TBL] [Abstract][Full Text] [Related]
7. Genetic approaches to identify pathological limitations in aortic smooth muscle contraction. Huang J; Gao N; Wang S; Milewicz DM; Kamm KE; Stull JT PLoS One; 2018; 13(3):e0193769. PubMed ID: 29494672 [TBL] [Abstract][Full Text] [Related]
8. Protein-elongating mutations in MYH11 are implicated in a dominantly inherited smooth muscle dysmotility syndrome with severe esophageal, gastric, and intestinal disease. Gilbert MA; Schultz-Rogers L; Rajagopalan R; Grochowski CM; Wilkins BJ; Biswas S; Conlin LK; Fiorino KN; Dhamija R; Pack MA; Klee EW; Piccoli DA; Spinner NB Hum Mutat; 2020 May; 41(5):973-982. PubMed ID: 31944481 [TBL] [Abstract][Full Text] [Related]
9. Smooth-muscle myosin mutations in hereditary non-polyposis colorectal cancer syndrome. Vickaryous N; Polanco-Echeverry G; Morrow S; Suraweera N; Thomas H; Tomlinson I; Silver A Br J Cancer; 2008 Nov; 99(10):1726-8. PubMed ID: 18941465 [TBL] [Abstract][Full Text] [Related]
10. Molecular Characterization of KRAS, BRAF, and EGFR Genes in Cases with Prostatic Adenocarcinoma; Reporting Bioinformatics Description and Recurrent Mutations. Salmaninejad A; Ghadami S; Dizaji MZ; Golchehre Z; Estiar MA; Zamani MR; Ebrahimzadeh-Vesal R; Nowroozi MR; Shakoori A Clin Lab; 2015; 61(7):749-59. PubMed ID: 26299074 [TBL] [Abstract][Full Text] [Related]
11. Gata2 deficiency delays leukemogenesis while contributing to aggressive leukemia phenotype in Cbfb-MYH11 knockin mice. Saida S; Zhen T; Kim E; Yu K; Lopez G; McReynolds LJ; Liu PP Leukemia; 2020 Mar; 34(3):759-770. PubMed ID: 31624376 [TBL] [Abstract][Full Text] [Related]
12. A homozygous loss-of-function variant in MYH11 in a case with megacystis-microcolon-intestinal hypoperistalsis syndrome. Gauthier J; Ouled Amar Bencheikh B; Hamdan FF; Harrison SM; Baker LA; Couture F; Thiffault I; Ouazzani R; Samuels ME; Mitchell GA; Rouleau GA; Michaud JL; Soucy JF Eur J Hum Genet; 2015 Sep; 23(9):1266-8. PubMed ID: 25407000 [TBL] [Abstract][Full Text] [Related]
13. Reduced expression of the DNA glycosylase gene MUTYH is associated with an increased number of somatic mutations via a reduction in the DNA repair capacity in prostate adenocarcinoma. Shinmura K; Kato H; Kawanishi Y; Yoshimura K; Igarashi H; Goto M; Tao H; Inoue Y; Sugiyama T; Furuse H; Ozono S; Sugimura H Mol Carcinog; 2017 Feb; 56(2):781-788. PubMed ID: 27253753 [TBL] [Abstract][Full Text] [Related]
14. A New Variant in the MYH11 Gene in a Familial Case of Thoracic Aortic Aneurysm. Pucci L; Pointet A; Good JM; Davoine E; Cina V; Zanchi F; Deglise S; Duchosal LM; Kirsch M Ann Thorac Surg; 2020 Apr; 109(4):e279-e281. PubMed ID: 31473177 [TBL] [Abstract][Full Text] [Related]
15. Mutational and expressional analyses of SPOP, a candidate tumor suppressor gene, in prostate, gastric and colorectal cancers. Kim MS; Je EM; Oh JE; Yoo NJ; Lee SH APMIS; 2013 Jul; 121(7):626-33. PubMed ID: 23216165 [TBL] [Abstract][Full Text] [Related]
16. MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II. Pannu H; Tran-Fadulu V; Papke CL; Scherer S; Liu Y; Presley C; Guo D; Estrera AL; Safi HJ; Brasier AR; Vick GW; Marian AJ; Raman CS; Buja LM; Milewicz DM Hum Mol Genet; 2007 Oct; 16(20):2453-62. PubMed ID: 17666408 [TBL] [Abstract][Full Text] [Related]
17. Bone metastasis in prostate cancer: Recurring mitochondrial DNA mutation reveals selective pressure exerted by the bone microenvironment. Arnold RS; Fedewa SA; Goodman M; Osunkoya AO; Kissick HT; Morrissey C; True LD; Petros JA Bone; 2015 Sep; 78():81-6. PubMed ID: 25952970 [TBL] [Abstract][Full Text] [Related]